Carlsmed, Inc. (CARL)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $469.16M
Last updated: Nov 17, 2026 at 11:03 AM ET
Earnings
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 15.7% above its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 58.5, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Data
Related GNG Research
No research available
Be the first to write about CARL
News
CARL Valuation
CARL Profitability: Margins, ROIC and FCF
Carlsmed (CARL) has a gross margin of 77.0%, an operating margin of -59.0% and a net margin of -55.8%. It posts -36.7% ROIC and a -50.4% FCF margin.
- Gross margin
- 77.0%
- Operating margin
- -59.0%
- Net margin
- -55.8%
- ROIC
- -36.7%
- ROE
- -44.0%
- FCF margin
- -50.4%
- FCF yield
- -7.6%
Carlsmed Competitors
The companies most similar to Carlsmed (CARL) include Sophia Genetics SA, NRC Health and Simulations Plus.
Sector: Healthcare
Companies most similar to CarlsmedCARL Analyst Ratings
Carlsmed (CARL) has a Buy consensus from 5 analysts: 5 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 5
- Strong Buy
- 2
- Buy
- 3
- Hold
- 0
- Sell
- 0
- Strong Sell
- 0
CARL Bull Case vs Bear Case
Bull case
- CARL grew quarterly revenue 64.9% year over year.
- 100.0% of CARL's analyst ratings are Buy or Strong Buy.
Bear case
- CARL has a -55.8% net profit margin.
CARL Earnings: Beat Rate and Next Report
Carlsmed (CARL) beat the EPS estimate in 5 of the last 7 quarters (71.4%). Its next report is expected on Feb 24, 2027.
- Beat rate
- 5 of 7 quarters (71.4%)
- Average surprise
- 4.6%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.39
CARL Earnings Date
CARL reports Feb 24, 2027. The date is estimated.
CARL Earnings Call
The latest CARL earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptCARL ETF Holders
GNG tracks 4 ETFs that hold CARL. The largest weights:
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
- Vanguard Russell 2000 Index Fund ETF Shares (VTWO), <0.01% of the fund
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 10, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About CARL
When does CARL report earnings?
Carlsmed, Inc. (CARL) is expected to report earnings on Feb 24, 2027.
Does CARL pay dividends?
Carlsmed, Inc. (CARL) does not currently pay a regular dividend.
What is CARL's market cap?
Carlsmed, Inc. (CARL) has a market capitalization of $469.16M with a current stock price of $17.35.
Did CARL beat earnings estimates last quarter?
Yes. Carlsmed, Inc. (CARL) reported EPS of -$0.34 for the quarter ended Sep 30, 2026, above the -$0.42 estimate, a 19.0% surprise.
CARL pages: Overview, Forecast, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.